Phase 4Completed
Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF) (PREDICT)
Effect of Highly Purified Menotrophin and Recombinant Follicle Stimulating (rFSH, Follitrophin Alpha) in Subfertile Female Patients Undergoing IVF on Progesterone Serum Levels During the Follicular Phase and Their Possible Use as Predictors for the Success Rate of Ongoing Pregnancies
- Sponsor
- Ferring Pharmaceuticals (Industry)
- Enrolment
- 124 enrolled
- Conditions
- Infertility
- Interventions
- Menotrophin; Follitrophin alpha; Cetrorelix; Choriongonadotropin; Progesterone
- Ages
- adults
- Registry
- NCT01225835, EUCTR2010-019411-37
Full record on ClinicalTrials.gov
From the registry
This study is aimed to demonstrate that highly purified Menotrophin produces significant lower progesterone serum levels during the follicular phase in comparison to Follitropin alpha in the treatment of subfertile females undergoing an in vitro fertilisation (IVF) and to investigate if the progesterone serum levels might be a useful predictor for the success rate of the ongoing pregnancy rates
Primary outcomes
- Serum Progesterone (P4) Level in the Morning of the Day of Human Chorionic Gonadotrophin (hCG) Administration
History
Last registry update
Results first posted
Study completion
Primary completion
Registered
Started